DM-1 | Genetic confirmation | 225 |
Clinical phenotype + pedigree | 97 |
FSHD | Genetic confirmation | 32 |
Clinical phenotype + pedigree | 9 |
LGMD2 | Genetic confirmation | 27 |
Clinical phenotype + pedigree | 4 |
LGMD2C | Clinical phenotype + muscle biopsy | 2 |
OPMD | Genetic confirmation | 5 |
EDMD | Genetic confirmation | 5 |
DMD | Genetic confirmation | 13 |
Clinical phenotype + muscle biopsy | 2 |
BMD | Genetic confirmation | 7 |
Dystroglycanopathies | Genetic confirmation | 1 |
Clinical phenotype + pedigree | 1 |
Clinical phenotype + muscle biopsy | 1 |
Unclassified CMD | Clinical phenotype + muscle biopsy | 2 |
GSD-II | Genetic confirmation | 2 |
GSD-V | Genetic confirmation | 4 |
Clinical phenotype + muscle biopsy | 2 |
Unclassified GSD | Clinical phenotype + muscle biopsy | 2 |
Lipid storage disease | Genetic confirmation | 1 |
Central Core | Clinical phenotype + muscle biopsy | 2 |
Myosin storage myopathy | Genetic confirmation | 2 |
Clinical phenotype + muscle biopsy | 1 |
Nemaline myopathy | Genetic confirmation | 1 |
Clinical phenotype + muscle biopsy | 2 |
Fibre type disproportion | Clinical phenotype + muscle biopsy | 3 |
Zaspopathy | Genetic confirmation | 4 |
Clinical phenotype + pedigree | 2 |
Distal myopathies | Clinical phenotype + magnetic resonance imaging patterns | 3 |